Skip to main content
TipRanks
Go Ultimate75% OFF

Xencor (XE9) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

XE9 Analyst Ratings

Strong Buy
11Ratings
9Buy2Hold0Sell
Based on 11 analysts giving stock ratings to Xencor in the past 3 months

XE9 Stock 12 Month Forecast

CHF34.34▲(0.00% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Xencor in the last 3 months. The average price target is CHF 34.34 with a high forecast of CHF 38.42 and a low forecast of CHF 21.72. The average price target represents a ― change from the last price of ―.
Highest Price TargetCHF38.42Average Price TargetCHF34.34Lowest Price TargetCHF21.72

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:XE9
Price TargetArticle
Canaccord GenuityCHF33.41buy―Reiterated11/10/26
RBC CapitalCHF35.92buy―Reiterated11/09/26
BarclaysCHF37.59buy―Reiterated11/05/26
TD Cowen―buy―Reiterated11/05/26
Leerink Partners Analyst forecast on CH:XE9Unknown AnalystNot RankedLeerink PartnersCHF34.25buy―Reiterated11/05/26
WedbushCHF37.59buy―Reiterated11/05/26
Wells FargoCHF25.06→CHF36.75buy―Assigned10/27/26
Truist FinancialCHF24.22→CHF33.41buy―Reiterated10/27/26
Bank of America SecuritiesCHF21.72hold―Reiterated10/26/26
J.P. Morgan―hold―Reiterated10/26/26
Raymond JamesCHF38.42buy―Assigned09/01/26
Cantor FitzgeraldCHF36.75buy―Reiterated08/10/26
William Blair―buy―Reiterated08/06/26
Piper SandlerCHF27.56buy―Reiterated08/06/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
QUITAchieve Life Sciences
COGTCogent Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Xencor

3 Months
Success Rate10/14 ratings generated profit
71%
Average Return
+25.94%

Copying David Nierengarten's trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +25.94% per trade.

1 Year
John Newman
John NewmanCanaccord Genuity
Success Rate10/14 ratings generated profit
71%
Average Return
+54.09%

Copying John Newman's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +54.09% per trade.

2 Years
John Newman
John NewmanCanaccord Genuity
Success Rate13/14 ratings generated profit
93%
Average Return
+140.17%

Copying John Newman's trades and holding each position for 2 Years would result in 92.86% of your transactions generating a profit, with an average return of +140.17% per trade.

XE9 Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for XE9
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy87783
Buy710141720
Hold31365
Sell00000
Strong Sell00000
total1818243128

In the current month, XE9 has received 23 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. XE9 average Analyst price target in the past 3 months is 34.34.

XE9 Financial Forecast

CHF-3CHF-2CHF-1CHF0CHF1Q1 2026Q3 2026Q4 2026
HighCHF0.14
ConsensusCHF-0.66
LowCHF-1.09

XE9 Earnings Forecast

Next quarter’s earnings estimate for XE9 is -CHF 0.66 with a range of -CHF 1.09 to CHF 0.14. The previous quarter’s EPS was CHF 0.42. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF2.6MCHF26.4MCHF50.2MCHF74MCHF97.8MQ1 2026Q3 2026Q4 2026
HighCHF67.5M
ConsensusCHF24.5M
LowCHF2.61M

XE9 Sales Forecast

Next quarter’s sales forecast for XE9 is CHF 24.48M with a range of CHF 2.61M to CHF 67.47M. The previous quarter’s sales results were CHF 97.78M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

XE9 Stock Forecast FAQ

What is CH:XE9’s average 12-month price target, according to analysts?
Based on analyst ratings, Xencor’s 12-month average price target is CHF34.34.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Xencor a Buy, Sell or Hold?
Xencor has a consensus rating of Strong Buy, which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.
What is Xencor’s share price target?
The average share price target for Xencor is CHF34.34. This is based on 11 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF38.42, and the lowest forecast is CHF21.72. The average share price target represents a 0.00% increase from the current price of ―.
What do analysts say about Xencor?
Xencor’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Street analysts.
How can I buy shares of Xencor?
To buy shares of CH:XE9, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.